| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |